Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genesco (GCO) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Genesco (GCO) over the last 16 years, with Q4 2025 value amounting to -$1.3 million.

  • Genesco's Other Working Capital Changes rose 5296.55% to -$1.3 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$2.6 million, marking a year-over-year decrease of 13826.27%. This contributed to the annual value of $61.2 million for FY2025, which is 34812.94% up from last year.
  • Genesco's Other Working Capital Changes amounted to -$1.3 million in Q4 2025, which was up 5296.55% from -$58.4 million recorded in Q3 2025.
  • Over the past 5 years, Genesco's Other Working Capital Changes peaked at $160.6 million during Q1 2021, and registered a low of -$58.4 million during Q3 2025.
  • In the last 5 years, Genesco's Other Working Capital Changes had a median value of $4.3 million in 2023 and averaged $9.7 million.
  • As far as peak fluctuations go, Genesco's Other Working Capital Changes soared by 317176.2% in 2021, and later crashed by 92522.26% in 2025.
  • Genesco's Other Working Capital Changes (Quarter) stood at -$6.0 million in 2021, then skyrocketed by 698.54% to $35.7 million in 2022, then tumbled by 106.11% to -$2.2 million in 2023, then decreased by 22.03% to -$2.7 million in 2024, then soared by 52.97% to -$1.3 million in 2025.
  • Its Other Working Capital Changes was -$1.3 million in Q4 2025, compared to -$58.4 million in Q3 2025 and $6.7 million in Q2 2025.